Clinical Trial Update: Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adding a pectoserratus block to interscalene block in patients undergoing total shoulder arthroplasty is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shoulder Osteoarthritis

Snippet

Sponsor: University of Minnesota | Conditions: Total Shoulder Arthroplasty | Phase 4 | Status: RECRUITING